TP53 mutations are predictive and prognostic when co-occurring with ALK rearrangements in lung cancer

被引：13

作者：

Costa, D. B. ^{[1
]}

机构：

[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷 / 10期

基金：

美国国家卫生研究院;

关键词：

OPEN-LABEL; CRIZOTINIB; CHEMOTHERAPY; RESISTANCE; INHIBITORS; GUIDELINE; CERITINIB; GENE;

D O I：

10.1093/annonc/mdy339

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2028 / 2030

页数：4

共 31 条

[1] The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2) [J].

Aisner, Dara L. ;

Sholl, Lynette M. ;

Berry, Lynne D. ;

Rossi, Michael R. ;

Chen, Heidi ;

Fujimoto, Junya ;

Moreira, Andre L. ;

Ramalingam, Suresh S. ;

Villaruz, Liza C. ;

Otterson, Gregory A. ;

Haura, Eric ;

Politi, Katerina ;

Glisson, Bonnie ;

Cetnar, Jeremy ;

Garon, Edward B. ;

Schiller, Joan ;

Waqar, Saiama N. ;

Sequist, Lecia V. ;

Brahmer, Julie ;

Shyr, Yu ;

Kugler, Kelly ;

Wistuba, Ignacio I. ;

Johnson, Bruce E. ;

Minna, John D. ;

Kris, Mark G. ;

Bunn, Paul A. ;

Kwiatkowski, David J. .

CLINICAL CANCER RESEARCH, 2018, 24 (05) :1038-1047

[2] Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study [J].

Camidge, D. Ross ;

Bang, Yung-Jue ;

Kwak, Eunice L. ;

Iafrate, A. John ;

Varella-Garcia, Marileila ;

Fox, Stephen B. ;

Riely, Gregory J. ;

Solomon, Benjamin ;

Ou, Sai-Hong I. ;

Kim, Dong-Wan ;

Salgia, Ravi ;

Fidias, Panagiotis ;

Engelman, Jeffrey A. ;

Gandhi, Leena ;

Jaenne, Pasi A. ;

Costa, Daniel B. ;

Shapiro, Geoffrey I. ;

LoRusso, Patricia ;

Ruffner, Katherine ;

Stephenson, Patricia ;

Tang, Yiyun ;

Wilner, Keith ;

Clark, Jeffrey W. ;

Shaw, Alice T. .

LANCET ONCOLOGY, 2012, 13 (10) :1011-1019

[3] De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TM-naive lung adenocarcinoma [J].

Carney, Brian J. ;

Rangachari, Deepa ;

VanderLaan, Paul A. ;

Gowen, Kyle ;

Schrock, Alexa B. ;

Ali, Siraj M. ;

Costa, Daniel B. .

LUNG CANCER, 2017, 114 :108-110

[4] A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response [J].

Chen, Zhao ;

Cheng, Katherine ;

Walton, Zandra ;

Wang, Yuchuan ;

Ebi, Hiromichi ;

Shimamura, Takeshi ;

Liu, Yan ;

Tupper, Tanya ;

Ouyang, Jing ;

Li, Jie ;

Gao, Peng ;

Woo, Michele S. ;

Xu, Chunxiao ;

Yanagita, Masahiko ;

Altabef, Abigail ;

Wang, Shumei ;

Lee, Charles ;

Nakada, Yuji ;

Pena, Christopher G. ;

Sun, Yanping ;

Franchetti, Yoko ;

Yao, Catherine ;

Saur, Amy ;

Cameron, Michael D. ;

Nishino, Mizuki ;

Hayes, D. Neil ;

Wilkerson, Matthew D. ;

Roberts, Patrick J. ;

Lee, Carrie B. ;

Bardeesy, Nabeel ;

Butaney, Mohit ;

Chirieac, Lucian R. ;

Costa, Daniel B. ;

Jackman, David ;

Sharpless, Norman E. ;

Castrillon, Diego H. ;

Demetri, George D. ;

Jaenne, Pasi A. ;

Pandolfi, Pier Paolo ;

Cantley, Lewis C. ;

Kung, Andrew L. ;

Engelman, Jeffrey A. ;

Wong, Kwok-Kin .

NATURE, 2012, 483 (7391) :613-617

[5] Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases [J].

Costa, Daniel B. ;

Shaw, Alice T. ;

Ou, Sai-Hong I. ;

Solomon, Benjamin J. ;

Riely, Gregory J. ;

Ahn, Myung-Ju ;

Zhou, Caicun ;

Shreeve, S. Martin ;

Selaru, Paulina ;

Polli, Anna ;

Schnell, Patrick ;

Wilner, Keith D. ;

Wiltshire, Robin ;

Camidge, D. Ross ;

Crino, Lucio .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) :1881-1888

[6] Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: A Single-center Analysis [J].

DiStasio, Marcello ;

Chen, Yigu ;

Rangachari, Deepa ;

Costa, Daniel B. ;

Heher, Yael K. ;

VanderLaan, Paul A. .

CLINICAL LUNG CANCER, 2017, 18 (05) :E349-E356

[7] Non-Small Cell Lung Cancer, Version 5.2017 Clinical Practice Guidelines in Oncology [J].

Ettinger, David S. ;

Wood, Douglas E. ;

Aisner, Dara L. ;

Akerley, Wallace ;

Bauman, Jessica ;

Chirieac, Lucian R. ;

D'Amico, Thomas A. ;

DeCamp, Malcolm M. ;

Dilling, Thomas J. ;

Dobelbower, Michael ;

Doebele, Robert C. ;

Govindan, Ramaswamy ;

Gubens, Matthew A. ;

Hennon, Mark ;

Horn, Leora ;

Komaki, Ritsuko ;

Lackner, Rudy P. ;

Lanuti, Michael ;

Leal, Ticiana A. ;

Leisch, Leah J. ;

Lilenbaum, Rogerio ;

Lin, Jules ;

Loo, Billy W., Jr. ;

Martins, Renato ;

Otterson, Gregory A. ;

Reckamp, Karen ;

Riely, Gregory J. ;

Schild, Steven E. ;

Shapiro, Theresa A. ;

Stevenson, James ;

Swanson, Scott J. ;

Tauer, Kurt ;

Yang, Stephen C. ;

Gregory, Kristina ;

Hughes, Miranda .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (04) :504-535

[8] p53 Modulates Acquired Resistance to EGFR Inhibitors and Radiation [J].

Huang, Shyhmin ;

Benavente, Sergio ;

Armstrong, Eric A. ;

Li, Chunrong ;

Wheeler, Deric L. ;

Harari, Paul M. .

CANCER RESEARCH, 2011, 71 (22) :7071-7079

[9] Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial [J].

Kim, Dong-Wan ;

Tiseo, Marcello ;

Ahn, Myung-Ju ;

Reckamp, Karen L. ;

Hansen, Karin Holmskov ;

Kim, Sang-We ;

Huber, Rudolf M. ;

West, Howard L. ;

Groen, Harry J. M. ;

Hochmair, Maximilian J. ;

Leighl, Natasha B. ;

Gettinger, Scott N. ;

Langer, Corey J. ;

Rodriguez, Luis G. Paz-Ares ;

Smit, Egbert F. ;

Kim, Edward S. ;

Reichmann, William ;

Haluska, Frank G. ;

Kerstein, David ;

Camidge, D. Ross .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (22) :2490-+

[10] Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer [J].

Kron, A. ;

Alidousty, C. ;

Scheffler, M. ;

Merkelbach-Bruse, S. ;

Seidel, D. ;

Riedel, R. ;

Ihle, M. A. ;

Michels, S. ;

Nogova, L. ;

Fassunke, J. ;

Heydt, C. ;

Kron, F. ;

Ueckeroth, F. ;

Serke, M. ;

Krueger, S. ;

Grohe, C. ;

Koschel, D. ;

Benedikter, J. ;

Kaminsky, B. ;

Schaaf, B. ;

Braess, J. ;

Sebastian, M. ;

Kambartel, K. -O. ;

Thomas, R. ;

Zander, T. ;

Schultheis, A. M. ;

Buettner, R. ;

Wolf, J. .

ANNALS OF ONCOLOGY, 2018, 29 (10) :2068-2075

← 1 2 3 4 →